Thus, our findings indicate MAT2A and MAT2B as new putative therapeutic targets for HCC and underline the need of further work to evaluate the therapeutic potential of miR-203 mimics against HCC. This evidence concerns the gene MAT2B and hepatocellular carcinoma.